Literature DB >> 27197202

c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.

Yihao Li1, Ke Jin2, Gabi W van Pelt3, Hans van Dam4, Xiao Yu5, Wilma E Mesker3, Peter Ten Dijke6, Fangfang Zhou7, Long Zhang8.   

Abstract

The molecular underpinnings of aggressive breast cancers remain mainly obscure. Here we demonstrate that activation of the transcription factor c-Myb is required for the prometastatic character of basal breast cancers. An analysis of breast cancer patients led us to identify c-Myb as an activator of Wnt/β-catenin signaling. c-Myb interacted with the intracellular Wnt effector β-catenin and coactivated the Wnt/β-catenin target genes Cyclin D1 and Axin2 Moreover, c-Myb controlled metastasis in an Axin2-dependent manner. Expression microarray analyses revealed a positive association between Axin2 and c-Myb, a target of the proinflammatory cytokine IL1β that was found to be required for IL1β-induced breast cancer cell invasion. Overall, our results identified c-Myb as a promoter of breast cancer invasion and metastasis through its ability to activate Wnt/β-catenin/Axin2 signaling. Cancer Res; 76(11); 3364-75. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27197202     DOI: 10.1158/0008-5472.CAN-15-2302

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.

Authors:  Zesen Shang; Jiao Zhao; Qi Zhang; Cheng Cao; Shanshan Tian; Kai Zhang; Ling Liu; Lei Shi; Na Yu; Shangda Yang
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

2.  Transcription factor c-Myb: novel prognostic factor in osteosarcoma.

Authors:  Kamila Říhová; Monika Dúcka; Iva Staniczková Zambo; Ladislava Vymětalová; Martin Šrámek; Filip Trčka; Jan Verner; Stanislav Drápela; Radek Fedr; Tereza Suchánková; Barbora Pavlatovská; Eva Ondroušková; Irena Kubelková; Danica Zapletalová; Štěpán Tuček; Peter Múdry; Dagmar Adámková Krákorová; Lucia Knopfová; Jan Šmarda; Karel Souček; Lubor Borsig; Petr Beneš
Journal:  Clin Exp Metastasis       Date:  2022-01-07       Impact factor: 5.150

3.  USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.

Authors:  Feng Xie; Xiaoxue Zhou; Huib Ovaa; Heyu Li; Peng Su; Sijia Liu; Ran Li; Jing Zou; Xiang Wei; Chen Pan; Zhengkui Zhang; Min Zheng; Zhuang Liu; Xuli Meng; Peter Ten Dijke; Fangfang Zhou; Long Zhang
Journal:  EMBO J       Date:  2022-07-11       Impact factor: 14.012

4.  MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer.

Authors:  Sanjeev Kumar Srivastava; Mohammad Aslam Khan; Shashi Anand; Haseeb Zubair; Sachin Kumar Deshmukh; Girijesh Kumar Patel; Seema Singh; Joel Andrews; Bin Wang; James Elliot Carter; Ajay Pratap Singh
Journal:  Br J Cancer       Date:  2021-11-26       Impact factor: 9.075

5.  Chemotherapy-Induced Long Non-coding RNA 1 Promotes Metastasis and Chemo-Resistance of TSCC via the Wnt/β-Catenin Signaling Pathway.

Authors:  Zhaoyu Lin; Lijuan Sun; Shule Xie; Shanyi Zhang; Song Fan; Qunxing Li; Weixiong Chen; Guokai Pan; Weiwei Wang; Bin Weng; Zhang Zhang; Bodu Liu; Jinsong Li
Journal:  Mol Ther       Date:  2018-04-05       Impact factor: 11.454

6.  Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding.

Authors:  L Knopfová; E Biglieri; N Volodko; M Masařík; M Hermanová; J F Glaus Garzón; M Dúcka; T Kučírková; K Souček; J Šmarda; P Beneš; L Borsig
Journal:  Oncogene       Date:  2017-10-30       Impact factor: 9.867

7.  Genomic Characterization of de novo Metastatic Breast Cancer.

Authors:  Ana C Garrido-Castro; Liam F Spurr; Melissa E Hughes; Yvonne Y Li; Andrew D Cherniack; Priti Kumari; Maxwell R Lloyd; Brittany Bychkovsky; Romualdo Barroso-Sousa; Simona Di Lascio; Esha Jain; Janet Files; Ayesha Mohammed-Abreu; Max Krevalin; Colin MacKichan; William T Barry; Hao Guo; Daniel Xia; Ethan Cerami; Barrett J Rollins; Laura E MacConaill; Neal I Lindeman; Ian E Krop; Bruce E Johnson; Nikhil Wagle; Eric P Winer; Deborah A Dillon; Nancy U Lin
Journal:  Clin Cancer Res       Date:  2020-12-08       Impact factor: 13.801

Review 8.  For robust big data analyses: a collection of 150 important pro-metastatic genes.

Authors:  Yan Mei; Jun-Ping Yang; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-01-21

9.  Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7.

Authors:  Zhengkui Zhang; Yao Fan; Feng Xie; Hang Zhou; Ke Jin; Li Shao; Wenhao Shi; Pengfei Fang; Bing Yang; Hans van Dam; Peter Ten Dijke; Xiaofeng Zheng; Xiaohua Yan; Junling Jia; Min Zheng; Jin Jin; Chen Ding; Sheng Ye; Fangfang Zhou; Long Zhang
Journal:  Nat Commun       Date:  2017-12-13       Impact factor: 14.919

10.  ALX4, an epigenetically down regulated tumor suppressor, inhibits breast cancer progression by interfering Wnt/β-catenin pathway.

Authors:  Juntang Yang; Fei Han; Wenbin Liu; Hongqiang Chen; Xianglin Hao; Xiao Jiang; Li Yin; Yongsheng Huang; Jia Cao; Huidong Zhang; Jinyi Liu
Journal:  J Exp Clin Cancer Res       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.